ZNF217 and colorectal cancer: ZNF217 protein levels were associated with aggressive clinical markers (p < 0.05 [52] and p < 0.05 [21]) and shorter OS (univariate analysis, p = 0.028 [21]) in colorectal cancer and with shorter RFS (univariate analysis, p = 0.0016) and OS (univariate analysis, p = 0.019) in gastric carcinoma [80].